Kyndryl reported revenues of $3.74 billion for the quarter ended December 31, 2024, with a net income of $215 million, or $0.89 per diluted share. Adjusted pretax income was $160 million, and adjusted net income was $124 million, or $0.51 per diluted share. The company's total signings were $4.1 billion, reflecting a 10% year-over-year increase.
Kyndryl reported revenues of $3.8 billion, a net loss of $43 million, and record total signings of $5.6 billion, which is a 132% increase year-over-year. The company reaffirms its outlook for fiscal year 2025, expecting constant-currency revenue growth in the fourth quarter.
Kyndryl's Q1 2025 results showed a revenue of $3.74 billion and a net income of $11 million. The company experienced growth in Kyndryl Consult and hyperscaler-related revenues. They are on track to deliver top-line growth in the fourth quarter of this fiscal year.
Kyndryl's Q4 2024 results showed a revenue of $3.8 billion, a net loss of $45 million, and an adjusted EBITDA of $566 million. The company is focusing on strategic initiatives and expects a return to revenue growth in Q4 2025.
Kyndryl reported revenues of $3.9 billion for the quarter ended December 31, 2023, a 9% year-over-year decline. The company reported a net loss of $12 million, or ($0.05) per diluted share, compared to a net loss of $106 million, or ($0.47) per diluted share, in the prior-year period. Adjusted EBITDA of $615 million increased 6% compared to $580 million in the prior-year period. The company is raising its fiscal 2024 outlook for adjusted pretax income to at least $150 million and raising its fiscal 2024 outlook for adjusted EBITDA margin to at least 14.5%.
Kyndryl reported revenues of $4.1 billion for the quarter ended September 30, 2023, a year-over-year decline of 3%. The company reported a net loss of $142 million, or ($0.62) per diluted share. Adjusted EBITDA of $574 million increased 34% compared to the prior-year period. The company is raising its fiscal 2024 adjusted earnings outlook.
Kyndryl reported revenues of $4.2 billion, a net loss of $141 million, and adjusted EBITDA of $612 million. The company is raising its fiscal year 2024 adjusted EBITDA margin outlook to approximately 14% and adjusted pretax income outlook to at least $100 million.
Kyndryl reported Q4 2023 revenues of $4.3 billion and a net loss of $737 million, while adjusted EBITDA stood at $476 million and adjusted pretax loss was $61 million. The company exceeded first-year targets for Alliances, Advanced Delivery and Accounts initiatives. They also provided outlook for fiscal year 2024, reflecting continuing progress on the ‘three-A initiatives’
Kyndryl reported revenues of $4.3 billion, a net loss of $106 million, and an adjusted pretax loss of $4 million. The company is making progress on its Alliances, Advanced Delivery and Accounts initiatives and raises revenue outlook and reaffirms margin outlook for fiscal year 2023.
Kyndryl's Q2 2023 results showed a revenue of $4.2 billion, a net loss of $281 million, and an adjusted pretax loss of $102 million. The company is making progress on its Alliances, Advanced Delivery, and Accounts initiatives and launched Kyndryl Bridge, Kyndryl Vital and Kyndryl Consult.
Kyndryl reported revenues of $4.3 billion for the quarter ended June 30, 2022, a year-over-year decline of 10%. The company's net loss was $250 million, or $1.11 per diluted share. The company is focused on delivering its fiscal year 2023 financial objectives.
Kyndryl reported revenues of $4.4 billion for the quarter ended March 31, 2022, a year-over-year decline of 7%. The company reported a net loss of $229 million, or $1.02 per diluted share. Signings totaled $3.1 billion, an increase of 27% in constant currency.
Kyndryl reported revenues of $4.6 billion, a pretax loss of $732 million, and a net loss of $740 million, or $3.30 per diluted share, for the quarter ended December 31, 2021. Pro forma revenue was $4.6 billion and pro forma signings were $4.4 billion. Pro forma adjusted EBITDA was $667 million and pro forma adjusted pretax income was $53 million.